Document Detail


Development of a human whole blood assay for prediction of cytokine release similar to anti-CD28 superagonists using multiplex cytokine and hierarchical cluster analysis.
MedLine Citation:
PMID:  21689786     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Anti-CD28 superagonist (SA) mediated cytokine release syndrome (CRS), an adverse event resulting in systemic release of cytokines, is an emergent issue in drug development. CRS is of potential concern for all monoclonal antibodies (mAbs) particularly those directed against cell surface targets on lymphocytes. Concern regarding patient safety requires development of novel methods to predict these adverse reactions. Due to the inability of animal studies to predict CRS, we have developed a whole blood in vitro screen to support First in Human studies and assess the potential for mAbs to cause anti-CD28 SA-like CRS. For this purpose we have immobilized marketed mAbs, whose potential for causing CRS and milder infusion reactions is known, on Protein A beads and used these beads to stimulate cytokine release. After culture, supernatants are harvested and frozen for later multiplex analysis of cytokines using Searchlight™ technology. We have employed hierarchicalluster analysis (HCA) to allow comparison of 12 different cytokine levels across numerous donors, treatments, and experiments. Results conclusively distinguish test mAb responses from an anti-CD28 superagonist mAb response. As part of a global analysis of preclinical data, the results of this assay can facilitate entry into First in Human clinical trials, help with selection of starting doses and may allow more rapid dose escalation using smaller cohorts.
Authors:
Mindi R Walker; Dorie A Makropoulos; Ram Achuthanandam; Scott Van Arsdell; Peter J Bugelski
Related Documents :
16988446 - In vitro assay of immunostimulatory activities of plasmid vectors.
20163626 - Identification of a potent immunostimulatory oligodeoxynucleotide from streptococcus th...
9593046 - Rapid induction of jak2 and sp1 in t cells by phosphorothioate oligonucleotides.
9423836 - The pseudomonas aeruginosa quorum-sensing signal molecule n-(3-oxododecanoyl)-l-homoser...
16988326 - A stereological analysis of the response of spermatogenesis to an acute inflammatory ep...
19580806 - Mechanism of glutamate-induced neurotoxicity in ht22 mouse hippocampal cells.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-17
Journal Detail:
Title:  International immunopharmacology     Volume:  -     ISSN:  1878-1705     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100965259     Medline TA:  Int Immunopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier B.V.
Affiliation:
Biologics Toxicology, Center of Excellence in Biotechnology, Centocor R&D Inc., Radnor, PA, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genetic evolution and clinical impact in extended-spectrum ?-lactamase-producing Escherichia coli an...
Next Document:  MicroRNAs as a novel cellular senescence regulator.